Impact of federal antipsychotic use policy in nursing homes on new diagnoses for approved indications in dementia residents.

ABSTRACT:

Background

Federal policies targeting antipsychotic use among nursing home (NH) residents may have increased reporting of diagnoses for approved uses, including schizophrenia, Tourette's syndrome, and Huntington's Disease (called "exclusionary diagnoses" because they exclude residents from the antipsychotic quality metric). We assessed changes in new exclusionary diagnoses among long-stay NH admissions specifically with dementia following federal policies.

Methods

Retrospective, quarterly, interrupted time-series analysis (2009-2018) of new long-stay NH residents with dementia and no exclusionary diagnoses reported before NH admission. The National Partnership and the addition of facility level antipsychotic use to the Five Star Quality Rating system were key time exposures.

SUBMITTER: Shireman TI 

PROVIDER: S-EPMC11637966 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature